On the 22nd of July 2025, EUROCHAM Malaysia’s Healthcare Sector Committee reconvened today to align our advocacy priorities, especially in relation to the ongoing Malaysia-EU Free Trade Agreement (MEUFTA) negotiations.
Healthcare remains a critical pillar of economic relations, and the committee aims to ensure that the interests of the healthcare industry are well-represented in shaping trade policy and regulatory frameworks.We would like to extend our sincere appreciation to the outgoing Committee leadership for the continued support and welcome Mr. Jegatheswaran Panderengen as the new Head of Committee as we move forward with a sharpened strategic agenda.
Thank you to all members who participated in today’s meeting and for your continued support to EUROCHAM Malaysia in strengthening EU-Malaysia cooperation.
Attendees of the meeting:
Mr. Jegatheswaran Panderengen, Novartis Malaysia
Mr. Mokhtar Azhan Nazri, Fresenius Medical Care
Mr. Azeem Shah M., Zuellig Pharma Malaysia
Mr. Nitiakaran (Leo) Selvaraj, Siemens Healthineers
Mr. Aeron Oh, Roche
Mr. Karl Godderis, CEO of EUROCHAM Malaysia
Ms. Jayanthi Palani, Head of Advocacy, EUROCHAM Malaysia.
Mr. Shaik Irfan, Government Relations Executive, EUROCHAM Malaysia
